Laman UtamaE2XA34 • BVMF
Exact Sciences Corp
R$32.45
16 Jan, 6:36:07 PG GMT-3 · BRL · BVMF · Penafian
Sekuriti tersenarai BRIbu pejabat di AS
Tutup sebelumnya
R$32.45
Julat hari
R$32.45 - R$32.45
Julat tahun
R$22.74 - R$42.10
Permodalan pasaran
9.91B USD
Bilangan Purata
544.00
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(USD)Sep 2024Perubahan T/T
Hasil
708.66J12.78%
Perbelanjaan pengendalian
531.08J-0.43%
Pendapatan bersih
-38.24J-4,915.62%
Margin untung bersih
-5.40-4,253.85%
Pendapatan bagi setiap syer
-0.1359.97%
EBITDA
36.28J270.41%
Kadar cukai berkesan
-2.16%
Jumlah aset
Jumlah liabiliti
(USD)Sep 2024Perubahan T/T
Pelaburan tunai dan jangka pendek
1.02B39.04%
Jumlah aset
6.75B5.10%
Jumlah liabiliti
3.54B7.23%
Jumlah ekuiti
3.21B
Syer tertunggak
185.08J
Harga kepada buku
1.87
Pulangan pada aset
-0.69%
Pulangan pada modal
-0.77%
Perubahan bersih dalam tunai
(USD)Sep 2024Perubahan T/T
Pendapatan bersih
-38.24J-4,915.62%
Tunai daripada operasi
138.72J469.43%
Tunai daripada pelaburan
-81.72J-147.86%
Tunai daripada pembiayaan
-226.00K-345.65%
Perubahan bersih dalam tunai
58.65J701.48%
Aliran tunai bebas
107.80J982.44%
Perihal
Exact Sciences Corp. is an American molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer. Since then Exact Sciences has grown its product portfolio to encompass other screening and precision oncological tests for other types of cancer. Wikipedia
Diasaskan
1 Jan 1995
Pekerja
6,550
Cari
Kosongkan carian
Tutup carian
Apl Google
Menu utama